NeoPharm, Inc. · Lake Bluff, IL United States
| 101 Waukegan Rd., Ste. 970 | Phone: 847-887-0800 |
| Lake Bluff, IL | Fax: 847-406-1764 |
| 60044 | |
| United States | 
Map This Company |
NeoPharm, Inc. Rankings
Company Description
NeoPharm is developing new drugs for cancer. The biopharmaceutical firm's lead drug candidate Cintredekin Besudotox is in late-stage clinical trials to treat recurrent glioblastoma multiforme (deadly brain tumors). However the candidate's approval by the FDA has been delayed. While the company is proceeding with further development of Cintredekin Besudotox, NeoPharm is also focused on developing its NeoLipid drug delivery technology, which is used to enhance and lessen side effects existing cancer drugs. In 2010 the company expanded its research programs when it was acquired by
NeoPharm, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
Executives
6 executives listed for NeoPharm, Inc.'s Lake Bluff, IL location.
| Chairman | John Kapoor | |
|---|---|---|
| Director | Frank Becker | |
| Director | Paul Freiman |